Hematological Malignancies

EL4 model of T cell Lymphoma

** ++

100

Control 5x2Gy RT

75

EG7 model of T cell Lymphoma

3mg/kg R848 q1w

50

3mg/kg R848 q1w + 5x2Gy RT

Control 10Gy + 3mg/kg R848 q1w 10Gy + 3mg/kg R848 q1w + α CD8 mAb ***

25

100

Percent survival

0

75

0

20

40

60

Time after tumour implantation (days)

50

A20 model of B cell Lymphoma

25

** +

Percent survival

100

0

0

20

40

60

NT

Time after tumor implantation (days)

75

3 mg/kg R848 q1w 5x2Gy RT 5x2Gy RT + 3 mg/kg R848 q1w

50

25

Percent survival

0

0

20

40

60

Time after tumor implantation (days)

Made with